Chronic prenatal exposure to cocaine alters cerebrovascular responses in newborn pigs

Experimental Biology and Medicine

Volumn 229, Issue 8, 2004, Pages 819-825

  Pourcyrous, Massroor ^a,b   Bada, Henrietta S ^a,c   Blaho, Kari E ^a   Randolph, Mildred M ^a   Parfenova, Helena ^a   Mandrell, Timothy D ^a   Arheart, Kris ^a,d   Korones, Sheldon B ^a   Leffler, Charles W ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Newborn Center   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Asphyxia; cAMP; Cocaine; Neonates; Pial arterioles

Indexed keywords

COCAINE; CYCLIC AMP; ISOPRENALINE; NORADRENALIN;

ANIMAL EXPERIMENT; ARTERIOLE; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; CEREBROSPINAL FLUID ANALYSIS; COCAINE DEPENDENCE; CONTROLLED STUDY; FEMALE; HYPERCAPNIA; LONG TERM EXPOSURE; NEWBORN; NONHUMAN; PERINATAL ASPHYXIA; PRENATAL DRUG EXPOSURE; THIRD TRIMESTER PREGNANCY; VAGINAL DELIVERY; VASOCONSTRICTION;

ANIMALIA;

EID: 4444228761     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020422900815     Document Type: Article

References (47)

1. Bada SB, Das A, Bauer CR, Shankaran S, Lester B, Wright LL, Verter J, Smeriglio VL, Finnegan LP, Maza PL. Gestational cocaine exposure and intrauterine growth: Maternal lifestyle study. Obstet Gynecol 100:916-924, 2002.
2. Smeriglio VL, Wilcox HC. Prenatal drug exposure and child outcome: Past, present, future. In: Lester BM, Ed. Clinical Perinatology: Prenatal drug exposure and child outcome. Philadelphia, PA: WB Saunders, pp1-16, 1999.
3. Behnke M, Davis EF, Conlon M, Wobie K, Stewart Woods N, Cummings W. Incidence and description of structural brain abnormalities in newborns exposed to cocaine. J Pediatr 132:291-294,1998.
4. Dusick AM, Cover RF, Schreiber MD, Yee GT, Browne SP, Moore CM, Tebbett IR. Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants. J Pediatr 122:438-445, 1993.
5. Zuckerman B, Frank D, Mayes L. Cocaine-exposed infants and developmental outcomes. "Crack kids" revisited. JAMA 287:1990-1991, 2002.
6. Ritchie JM, Greene NM. Local anesthetics. In: Gilman AF, Rall TW, Nies AS, Taylor P, Eds. The Pharmacological Basis of Therapeutics. New York: Pergamon Press, pp311-331, 1999.
7. Volpe JJ. Effect of cocaine use on the fetus. N Engl J Med 327:399-407, 1992.
8. Woods JR Jr, Plessinger MA, Clark KE. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 257:957-961, 1987.
9. Pourcyrous M, Parfenova H, Bada HS, Korones SB, Leffler CW. Changes in cerebral cyclic nucleotides and cerebral blood flow during prolonged asphyxia and recovery in newborn pigs. Pediatr Res 41:617-623, 1997.
10. Parfenova H, Shibata M, Zuckerman S, Mirro R, Leffler CL. Cyclic nucleotides and cerebrovascular tone in newborn pigs. Am J Physiol 270:C1503-C1515, 1993.
11. Greengard P. Adenosine 3′, 5′-cyclic monophosphate as a mediator in the action of neurohumeral agents. Biochem J 128:75-77, 1972.
12. Pourcyrous M, Bada HS, Yang W, Parfenova H, Wong S, Korones SB, Leffler CW. Prognostic significance of cerebrospinal fluid cyclic adenosine monophosphate in neonatal asphyxia. J Pediatr 134:90-96, 1999.
13. Anday EK, Goplerud JM, Kurt CD, Show LM. Pharmacokinetics and effect of cocaine on cerebral blood flow in newborn. Dev Pharmacol Ther 20:35-44, 1993.
14. Blaho K, Logan B, Winbery S, Park L, Schwinkle E. Blood cocaine and metabolite concentrations, clinical findings and outcome of patients presenting to an emergency department. Am J Emer Med 18(5):593-598, 2000.
15. Olsen GD. Potential mechanisms of cocaine-induced developmental neurotoxicity: a minireview. Neurotoxicology 16(1):159-168, 1995.
16. Tiggi G, Hong L, Yakubu M, Parfenova H, Leffler CW. Lysophosphatidic acid alters cerebrovascular reactivity in piglets. Am J Physiol 268:H2048-H2055, 1995.
17. Leffler CW, Fedinec A, Shibata M. Prostacyclin receptor activation and pial arteriolar dilation after endothelial injury in piglets. Stroke 26:2103-2111, 1995.
18. Chasnoff IJ, Anson A, Hatcher R, Stenson H, Iaukea K, Randolph LA. Prenatal exposure to cocaine and other drugs. Outcome at four to six years. Ann N Y Acad Sci 846:314-328, 1998.
19. Harvey JA, Kosofsky BE Eds. Cocaine: Effects on the developing brain. New York: The New York Academy of Sciences, 1988.
20. Pane MA, Traystman RJ, Gleason CA. Ecgonine methyl ester, a major cocaine metabolite, causes cerebral vasodilation in neonatal sheep. Pediatr Res 41:815-821, 1997.
21. Spear LP, Frambes NA, Kritein CL. Fetal and maternal brain and plasma levels of cocaine and benzoylecgonine following chronic subcutaneous administration of cocaine during gestation in rats. Psychopharmacology 97:427-431, 1989.
22. Lidow MS, Trakht T, Howard RL. Cocaine-induced alterations in the density of monoaminergic receptors in the embryonic guinea pig cerebral wall. Synapse 32(3):225-237, 1999.
23. Yakubu MA, Pourcyrous M, Randolph MM, Blaho KE, Mandrell TD, Bada HS, Leffler CW. Consequences of maternal cocaine on cerebral microvascular functions in piglets. Brain Res 947(2):174-181, 2002.
24. Seidler FJ, Slotkin TA. Fetal cocaine exposure causes persistent noradrenergic hyperreactivity in rat brain: effects on neurotransmitter turnover and receptors. J Pharmacol Exp Ther 263(2):413-421, 1992.
25. Kurth CD, Monitto C, Albuquerque ML, Feuer P, Anday E, Shaw L. Cocaine and its metabolites constrict cerebral arterioles in newbom pigs. J Pharmacol Exp Ther 265(2):587-591, 1993.
26. Leffler CW. Prostanoids: intrinsic modulators of cerebral circulation. NIPS 12:72-77, 1997.
27. Eichhorn EJ, Demian SE, Alvarez LG, Willard JE, Molina S, Bartula LL, Prince MD, Inman LR, Graybum PA, Myers SI. Cocaine-induced alterations in prostaglandin production in rabbit aorta. J Am Coll Cardiol 19:696-703, 1992.
28. 2 in the newborn pig cerebral circulation. Eur J Pharmacol 278:133-142, 1995.
29. Terwillinger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548(1-2):100-110, 1991.
30. Iida H, Gleason CA, O'Brien TS, Traystman RJ. Fetal responses to acute fetal cocaine injection in sheep. Am J Physiol 267:H1968-H1975, 1994.
31. Burchfield DJ, Pena A, Peters AJM, Abrams RM, Phillips D. Cocaine does not compromise cerebral or myocardial oxygen delivery in fetal sheep. Reprod Fertil Dev 8:383-389, 1996.
32. Gleason CA, Iida H, O'Brian TP, Jones MD, Jr., Cone EJ, Traystman RJ. Fetal responses to acute maternal cocaine injection in sheep. Am J Physiol 265:H9-H14, 1993.
33. Covert RF, Schreiber MD, Tebbett IR, Torgerson LJ. Hemodynamics and cerebral blood flow effects of cocaine, cocaethylene and benzoylecgonine in conscious and anesthetized fetal lambs. J Pharmacol Exp Ther 270:118-126, 1994.
34. Pena AE, Burchfield DJ, Abrams RM. Myocardial and cerebral oxygen delivery are not adversely affected by cocaine administration to early-gestation fetal sheep. Am J Obstet Gynecol 174:1028-1032, 1996.
35. O'Brien TP, Pane MA, Traystman RJ, Gleason CA. Propranolol blocks cocaine-induced cerebral vasodilation in newborn sheep. Crit Care Med 27:784-789, 1999.
36. Dohi S, Jones MD, Hudak ML, Traystman RJ. Effects of cocaine on pial arterioles in cats. Stroke 21:1710-1714, 1990.
37. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev 78:189-225, 1998.
38. Laurini RN, Arbeille B, Gemberg C, Akoka S, Locatelli A, Lansac J, Arbeille PH. Brain damage and hypoxia in an ovine fetal chronic cocaine model. Eur J Obstet Gynecol Reprod Biol 86:15-22, 1999.
39. Arbeille P, Maulik D, Salihagic A, Locatelli A, Lansac J, Platt LD. Effect of long-term cocaine administration to pregnant ewes on fetal hemodynamics, oxygenation, and growth. Obstet Gynecol 90:795-802, 1997.
40. Binienda ZK, Scallet AC. Neuroprotective effect of perinatal hypoxia against 3-nitropropionic acid neurotoxicity. In: Sandberg PR, Nishino H, Borlongan CV, Eds., Mitochondrial inhibitors and neurodegenerative disorders. Totowa, NJ: Humana Press, pp265-274, 2000.
41. Fahim I, Ismail M, Osman OH. Hypothermic effect of cocaine in rats. West Afr J Pharmacol Drug Res 2(1):48-56, 1975.
42. Slikker W, Desai VG, Duhart H, Feuers R, Imam SZ. Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in Chinese hamster ovary cells. Free Radical Biol Med 31(3):405-411, 2001.
43. Koide T, Wieloch TW, Siesjo BK. Circulating catecholamines modulating ischemic brain damage. J Cereb Blood Flow Metab 6:559-565, 1986.
44. Araki T, Kogure K, Izumiyama K. Prevention of ischemic neuronal damage by alpha 1-adrenergic agonist (methoxamine). Acta Neurol Scand 80:451-454, 1989.
45. Lee M, Vest JW, Lai Y, Scheuer T, Catterall WA. Functional modulation of brain sodium channels by cAMP-dependent phosphorylation. Neuron 8:1151-1159, 1992.
46. Muir JK, Ellis EF. Acute cocaine administration alters posttraumatic blood pressure and cerebral blood flow in rats. Am J Physiol 268:H68-H73, 1995.
47. Levine V, Pourcyrous M, Bada HS, Parfenova H, Yang W, Korones SB, Leffler CW. Preservation of cerebrovascular tone and reactivity by sodium channel inhibition in experimental prolonged asphyxia in piglets. Pediatr Res 47:376-380, 2000.